Investigators say classification based on magnetic resonance imaging can predict a patient’s risk of recurrence for intrahepatic cholangiocarcinoma (iCCA).
Preoperative liver imaging may help physicians better understand whether a patient is likely to experience recurrence following curative resection of intrahepatic cholangiocarcinoma (iCCA).
A new multicenter report published in Journal of Magnetic Resonance Imaging shows imaging classifications using the Liver Imaging Reporting and Data System (LI-RADS) correlate with 5-year recurrence-free survival (RFS) rates. The findings suggest LI-RADS classification based on contrast-enhanced MRI could be an important prognostic marker, alongside other factors like tumor size.
The authors explained that in patients with iCCA, complete tumor resection is the only potential curative treatment option. However, many patients still go on to experience recurrence after surgery, and the only widely accepted independent predictors of recurrence risk are factors such as lymphovascular and perineural invasion and lymph node metastasis, which can only be determined following the procedure itself.
The authors said preoperative imaging may offer an opportunity to better understand recurrence risk even before resection.
“Using LI-RADS when evaluating the imaging studies of high-risk patients may help ensure consistent and objective image analysis,” they wrote. If such consistency were achieved, it might be possible to assign recurrence risk based on LI-RADS assessment, they added.
LI-RADS was designed to help assess increased risk for hepatocellular carcinoma (HCC), a disease that has many of the same risk factors as iCCA. Scores can range from LR-1, which means a lesion is benign, to LR-5, a classification indicating malignancy that meets the criteria for HCC. In addition, the scoring system has other classifications, such as LR-M, which means a definite or likely malignancy, but which does not meet the criteria for HCC.
To test the potential for LI-RADS in assessing recurrence risk, the investigators conducted a retrospective, multicenter study in which 113 patients who underwent preoperative MRI and then curative surgical resection were categorized using LI-RADS and then tracked for long-term outcomes.
Most of the patients in the study (n = 93; 82.3%) were categorized as LR-M using LI-RADS. However, 17.7% were categorized as LR-4 or LR-5. The outcomes data showed that the latter group had significantly better outcomes.
Classification as LR-M and with tumor sizes in excess of 3 cm were both found to be independent risk factors for poor RFS. In addition, patients with LR-4 or LR-5 classifications had a 94.4% 5-year RFS rate compared with 51.9% seen among patients with an LR-M classification.
“Taken together, these findings suggest that the LI-RADS category may provide valuable prognostic implications for primary hepatic malignancy, regardless of the pathologic diagnosis,” the investigators concluded. They said their findings align with previous research looking at the potential of LI-RADS as a predictor of outcomes in patients with primary liver cancer.
The authors cautioned that because their study population was limited to people with single iCCAs, it is likely that the group includes patients with preserved liver function and lower tumor staging and thus are likely to have superior outcomes. They added that three-quarters of patients in this study had hepatitis B, so they said the study may have limited generalizability to other disease etiologies.
They concluded that further, larger studies will be needed to confirm the findings.
Reference
Hwang JA, Lee S, Lee JE, Yoon J, Choi SY, Shin J. LI-RADS category on MRI is associated with recurrence of intrahepatic cholangiocarcinoma after surgery: a multicenter study. J Magn Reson Imaging. Published online July 14, 2022. doi:10.1002/jmri.28354
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At The Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More